ESOPJul 17, 2026, 06:07 AM
NovaBridge Adopts 2026 Share Plan, Authorizes 11.96M Shares
AI Summary
NovaBridge Biosciences' Board of Directors adopted the 2026 Omnibus Share Incentive Plan on July 13, 2026. This plan authorizes the issuance of up to 11,960,000 Shares, equivalent to 5,200,000 American Depositary Shares, plus additional shares from predecessor plans. The plan also includes an annual increase provision of up to 3% of outstanding shares from 2027 to 2036, and is designed to attract, retain, and motivate key personnel through various equity and cash-based awards.
Key Highlights
- Board adopted the 2026 Omnibus Share Incentive Plan on July 13, 2026.
- Authorizes 11,960,000 Shares (5,200,000 American Depositary Shares) for issuance.
- Includes shares from predecessor plans and unissued shares from those plans.
- Annual increase of up to 3% of outstanding shares from 2027 through 2036.
- Replaces five previous share incentive plans; no new awards under old plans.
- Plan aims to attract, retain, and motivate employees, consultants, and directors.
- Awards include Options, SARs, Restricted Shares, Share Units, and Cash-Based Awards.
Price Impact
More from NBP